All In Biotech

Drug Trial Radar · NCT04844983

A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Last checked: Nov 19, 2026Latest source record: Mar 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

44

Actual

Start

May 18, 2021

Primary completion

Aug 24, 2022

Study completion Dec 6, 2022

Sponsor

Lead sponsor
SirnaomicsIndustry
Sponsor type
Industry
First posted
Apr 14, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma (in situ) skin cancer (isSCC).

Conditions

  • Squamous Cell Carcinoma in Situ

Interventions

  • STP705Drug

    The STP705 drug substance is composed of two siRNA oligonucleotides, targeting TGF-β1 and COX-2 mRNA respectively.

  • Placebo SalineOther

    Normal Saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with histological clearance of treated isSCC lesionTime frame: 6 weeks

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Investigate MD

    Scottsdale, Arizona

  • Center for Clinical and Cosmetic Research

    Aventura, Florida

  • Research Institute of the Southeast LLC

    West Palm Beach, Florida

  • Dermatology, Laser and Vein Specialists of the Carolinas

    Charlotte, North Carolina

  • Dermatology Associates of Knoxville

    Knoxville, Tennessee

  • Tennessee Clinical Research

    Nashville, Tennessee

  • Austin Institute for Clinical Research

    Pflugerville, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.